LeMaitre Vascular, Inc. (LMAT) earnings
LMAT earnings moved a median of +0.17% by the close. Quarterly and annual LMAT reports and results, each read against the price at its own news timestamp. Back to the LMAT overview →
25 measured LMAT earnings events.
Where these LMAT earnings landedvs 24 measured LMAT earnings reactions
| Middle 50% of LMAT earnings reactions | -1.27% to +1.04% |
|---|---|
| Median reaction (to close) | +0.17% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 LMAT earnings events with a measured close landed between -1.27% and +1.04%; 54% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026 | Press release | — | — | |
| Form 10-Q LEMAITRE VASCULAR INC For: Jun 30 | SEC filing · Form 10-Q | +2.73% | -8.14% | |
| LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026 | Press release | +0.41% | +2.19% | |
| Form 10-Q LEMAITRE VASCULAR INC For: Mar 31 | SEC filing · Form 10-Q | -7.28% | -3.04% | |
| LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026 | Press release | -0.52% | -2.17% | |
| Form 10-K LEMAITRE VASCULAR INC For: Dec 31 | SEC filing · Form 10-K | +5.99% | +10.32% | |
| LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026 | Press release | -0.34% | +1.01% | |
| Form 10-Q LEMAITRE VASCULAR INC For: Sep 30 | SEC filing · Form 10-Q | -1.34% | +4.57% | |
| LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025 | Press release | +0.00% | -1.82% | |
| Form 10-Q LEMAITRE VASCULAR INC For: Jun 30 | SEC filing · Form 10-Q | +0.39% | +0.21% | |
| LeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, 2025 | Press release | -0.32% | -0.15% | |
| Form 10-Q LEMAITRE VASCULAR INC For: Mar 31 | SEC filing · Form 10-Q | -0.42% | -1.39% | |
| LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025 | Press release | +0.13% | +0.13% | |
| Form 10-K LEMAITRE VASCULAR INC For: Dec 31 | SEC filing · Form 10-K | -0.21% | +1.13% | |
| LeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 27, 2025 | Press release | +0.36% | +1.18% | |
| Form 10-Q LEMAITRE VASCULAR INC For: Sep 30 | SEC filing · Form 10-Q | +0.10% | +1.36% | |
| LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024 | Press release | +0.22% | +0.28% | |
| Form 10-Q LEMAITRE VASCULAR INC For: Jun 30 | SEC filing · Form 10-Q | — | +0.35% | |
| LeMaitre Will Announce Second Quarter 2024 Earnings Results August 1, 2024 | Press release | +0.38% | -0.17% | |
| Form 10-Q LEMAITRE VASCULAR INC For: Mar 31 | SEC filing · Form 10-Q | — | +0.25% | |
| LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024 | Press release | -0.17% | -0.38% | |
| Form 10-K LEMAITRE VASCULAR INC For: Dec 31 | SEC filing · Form 10-K | -0.06% | +0.20% | |
| LeMaitre Will Announce Fourth Quarter 2023 Earnings Results February 27, 2024 | Press release | — | -2.40% | |
| Form 10-Q LEMAITRE VASCULAR INC For: Sep 30 | SEC filing · Form 10-Q | -0.20% | -0.38% | |
| LeMaitre Will Announce Third Quarter 2023 Earnings Results November 1, 2023 | Press release | -1.66% | -1.23% |
Keep exploring
More LMAT: analyst actions → · SEC filings → · LMAT overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Globus Medical, Inc. Class A (GMED) | 431 | +0.02% | 51% |
| SCYNEXIS, Inc. (SCYX) | 431 | 0.00% | 41% |
| TRULIEVE CANNABIS CORP (TCNNF) | 429 | +0.41% | 58% |
| Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA) | 427 | -0.21% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.